Form 4: Vicarious Surgical President Sells Shares for Tax Cover

Vicarious Surgical's President and Director, Adam David Sachs, sold 942 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Summary

• Adam David Sachs, President and Director of Vicarious Surgical Inc. (RBOT), reported a sale of 942 shares of Class A Common Stock.
• The transaction occurred on February 20, 2026, at a weighted average price of $2.0878 per share, with individual trades ranging from $1.845 to $2.290.
• The sale was non-discretionary and executed solely to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) that were granted on May 19, 2022.
• Following this transaction, Mr. Sachs beneficially owns 46,943 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was non-discretionary and solely for tax purposes, not reflecting a change in the insider's investment sentiment.

Positives

• The sale was non-discretionary, indicating it was not a reflection of management's view on the company's future prospects but rather a mandated tax-related event.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing.

Management Comments

• The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.
• The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that "sell to cover" transactions are common practice for executives receiving equity compensation, particularly restricted stock units, and are generally not indicative of a change in sentiment towards the company's prospects.

Comparison to Industry Standards

• This filing details a routine, non-discretionary insider transaction for tax purposes, which is a standard practice across publicly traded companies offering equity compensation, such as those in the medical technology or robotics sectors like Intuitive Surgical or Stryker, where equity awards are a significant part of executive compensation.

Related Party Transactions

• The reported transaction is a related party dealing involving the sale of shares by a company officer and director to cover tax obligations arising from equity compensation.

Stakeholder Impact

• Shareholders: The sale of 942 shares represents a minor dilution, but the non-discretionary nature of the transaction mitigates concerns about insider sentiment or a lack of confidence in the company's future.
• Employees: No direct impact on employees beyond the reporting person.

Key Dates

Recommendation

This Form 4 details a routine, non-discretionary "sell to cover" transaction by an insider for tax purposes. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate as this event is neutral to the company's fundamental outlook.

Keywords

Vicarious Surgical, RBOT, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Adam David Sachs, Corporate Governance